Contents Accolades Around Campus Hartford News Calendar Archives
Virtual Campus Tour Libraries Academics Research at Rensselaer Rensselaer News Contact Info Search Rensselaer Community
 
Campus.News July 28, 2003
   
 

Early Infection and Rejection Detection: Microdialysis Technique May Help Implants Stay Put Longer

Thomas Griffin  
Julie Stenken  
   
Millions of medical devices, including catheters, pacemakers, vascular grafts, and glucose sensors, are regularly implanted into humans. Despite the frequency of these procedures, implantation still poses a risk of serious side effects, including implant site infection and rejection of the implanted device. Julie Stenken, associate professor of analytical chemistry, has received a four-year, $750,000 grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) to develop a new technique to study the body’s reaction to implants at the cellular level. The microdialysis technique can provide information that may someday help doctors spot infection earlier and prevent rejection from occurring. Stenken is collaborating with Albany Medical Center co-investigators Daniel Loegering and Michelle Lennartz.

A microdialysis probe (the size of a 0.5 mm pencil lead) is used to withdraw a tiny sample of extracellular fluid at the site where the implant and the body’s tissues meet. Analysis of the sample can detect the presence and amount of a variety of chemical markers called cytokines that may indicate early signs of responses to an implant such as infection or rejection. “If you can understand the chemical communication that is going on at the implantation site, you can ultimately bioengineer the site to make it do what is appropriate for the device,” says Stenken. “The tools to measure these chemical reactions are just starting to become available to us.”

The NIBIB coordinates with the biomedical imaging and bioengineering programs of other agencies and the National Institutes of Health to support imaging and engineering research with potential medical applications.

Stenken’s microdialysis project is part of Rensselaer’s focal effort to advance biotechnology discoveries for the benefit of public health, the environment, homeland security, bioterrorism, and for positive economic development locally and globally.

 
News Home
Tell Us Your News
Sign Up for Campus.News Bulletin
Contact News Staff
 

Campus.News Features:

Dale Masten Named Pillar of Rensselaer

Early Infection and Rejection Detection: Microdialysis Technique May Help Implants Stay Put Longer

Office of Communications Names New Directors

Michael Shur Among Five "Blue Spectrum Pioneers" Honored by CompoundSemi Online

The LRC’s Narendran Elected Fellow of IESNA

Formula SAE Team Takes Second Place in UK Competition

 
News Links:
Press Releases
The Polytechnic
Rensselaer Mag
News & Ideas
Hartford Campus
News Staff
Sports News
Research News
South Campus Development News

 

 

Do you have news for this page? Tell Us Your News or send an e-mail to our editor.


Rensselaer News
News Home | Press Releases | News Archives
Campus.News | Research News | Tip Sheets | Events Calendar | Hartford Campus News
Communications | News Contacts | Rensselaer Magazine | Polytechnic

 
Campus Safety and Preparedness Home Page 

Rensselaer Polytechnic Institute

RPInfo | Search RPI | Contact RPI | RPI News | Research | Academics | Libraries | Tour & Map
President's Home Page | About Rensselaer | Campus.News | Dates & Events
Rensselaer Home Page | Future Students | Alumni & Friends | Campus Visitors | Institute Partners
Human Resources and Employment | Career Development Center

Rensselaer Polytechnic Institute (RPI), 110 8th St., Troy, NY 12180. (518) 276-6000
Copyright © 1996–2003 Rensselaer Polytechnic Institute. All rights reserved worldwide.
Why not change the world?(SM) is a service mark of Rensselaer Polytechnic Institute.

Web site design by the Rensselaer Office of Communications.
Contact
Jane Van Ryan, Assistant Vice President, Office of Communications  

Questions? Comment? Please contact us